ReviewiScience2026
Multiple triggering mechanisms of myocardial fibrosis: Comparison and integration in different disease contexts.
Review in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial fibrosis (MF) is a pathophysiological process characterized by the excessive deposition of collagen fibers in the myocardium. Numerous studies are now dedicated to clarifying the genetic, cellular, and molecular mechanisms that drive these pathological alterations. Furthermore, substantial evidence suggests that diffuse fibrosis causes irreversible damage to the heart. Myocardial fibrosis and cardiovascular disease are interrelated, influencing each other significantly. However, the existing evidence linking myocardial fibrosis to common diseases is still insufficient. In this review, we summarized the common mechanisms underlying myocardial fibrosis and their associations with prevalent cardiovascular diseases (e.g., myocardial infarction, heart failure, hypertrophic cardiomyopathy, dilated cardiomyopathy), and emphasized the heterogeneous presentations of myocardial fibrosis across different diseases to promote the future realization of personalized treatment for fibrosis-related cardiovascular diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.